ResearcherHumboldt-Universität zu BerlinActive in the last 2 years
Florian Nino Loch
Matched on ORCID iD 0000-0003-1513-8339; OpenAlex author ID A5006457234. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 14
2020: 1 paper · 2021: 2 papers · 2022: none · 2023: 1 paper · 2024: none · 2025: none · 2026: 2 papers
Papers 6
- Spatial heterogeneity of antibody-drug conjugate targets in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/2056-4538.70083↗
- Diagnostic Performance of Node-RADS for CT-based Assessment of Regional Lymph Nodes in Pancreatic Ductal Adenocarcinoma Last author DOI 10.21203/rs.3.rs-9115727/v1↗
- The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/ijms24032160↗
- Peptide Signatures for Prognostic Markers of Pancreatic Cancer by MALDI Mass Spectrometry Imaging. Co-author DOI 10.3390/biology10101033↗
- Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers14010201↗
- Novel methods for in vitro modeling of pancreatic cancer reveal important aspects for successful primary cell culture. Co-author DOI 10.1186/s12885-020-06929-8↗
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Carsten Kamphues · 5 shared papers, 2020–2026 · strength 0.80
- Paper Diagnostic Performance of Node-RADS for CT-based Assessment of Regional Lymph Nodes in Pancreatic Ductal Adenocarcinoma DOI 10.21203/rs.3.rs-9115727/v1↗
- Paper The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/ijms24032160↗
- Paper Peptide Signatures for Prognostic Markers of Pancreatic Cancer by MALDI Mass Spectrometry Imaging. DOI 10.3390/biology10101033↗
- Mihnea Paul Dragomir · 3 shared papers, 2021–2026 · strength 0.58
- Paper Spatial heterogeneity of antibody-drug conjugate targets in pancreatic ductal adenocarcinoma. DOI 10.1002/2056-4538.70083↗
- Paper The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/ijms24032160↗
- Paper Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14010201↗
- Simon Schallenberg · 3 shared papers, 2021–2026 · strength 0.58
- Paper Spatial heterogeneity of antibody-drug conjugate targets in pancreatic ductal adenocarcinoma. DOI 10.1002/2056-4538.70083↗
- Paper The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/ijms24032160↗
- Paper Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14010201↗
- Katharina Beyer · 4 shared papers, 2020–2023 · strength 0.53
- Paper The Immune Checkpoint Landscape in Tumor Cells of Pancreatic Ductal Adenocarcinoma. DOI 10.3390/ijms24032160↗
- Paper Peptide Signatures for Prognostic Markers of Pancreatic Cancer by MALDI Mass Spectrometry Imaging. DOI 10.3390/biology10101033↗
- Paper Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14010201↗
- Frederick Klauschen · 3 shared papers, 2020–2026 · strength 0.51
- Paper Spatial heterogeneity of antibody-drug conjugate targets in pancreatic ductal adenocarcinoma. DOI 10.1002/2056-4538.70083↗
- Paper Peptide Signatures for Prognostic Markers of Pancreatic Cancer by MALDI Mass Spectrometry Imaging. DOI 10.3390/biology10101033↗
- Paper Novel methods for in vitro modeling of pancreatic cancer reveal important aspects for successful primary cell culture. DOI 10.1186/s12885-020-06929-8↗
- Georgios Antonios Margonis · 3 shared papers, 2020–2021 · strength 0.35
- Paper Peptide Signatures for Prognostic Markers of Pancreatic Cancer by MALDI Mass Spectrometry Imaging. DOI 10.3390/biology10101033↗
- Paper Rethinking the TNM Classification Regarding Direct Lymph Node Invasion in Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers14010201↗
- Paper Novel methods for in vitro modeling of pancreatic cancer reveal important aspects for successful primary cell culture. DOI 10.1186/s12885-020-06929-8↗
- Deema Sabtan · 1 shared paper, 2026 · strength 0.28
- Marcus Bahra · 1 shared paper, 2026 · strength 0.27
- Rolf Reiter · 1 shared paper, 2026 · strength 0.27
- Ingolf Sack · 1 shared paper, 2026 · strength 0.27
- Oliver Klein · 1 shared paper, 2021 · strength 0.13
- Fiona Speichinger · 1 shared paper, 2021 · strength 0.12
- Ioannis Pozios · 1 shared paper, 2021 · strength 0.12
- Lukas Ehlen · 1 shared paper, 2020 · strength 0.10
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.